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Trouble-making 
NKT cells
 
The dark side of NKT cells is revealed in a new 
study showing that they contribute to 
autoimmune arthritis in mice. On page 41, Kim 
et al. find that arthritis is worse in joints that are 
invaded by NKT cells.
NKT cells are innate immune cells that express 
both NK and T cell markers, and are protective in 
many other models of autoimmune disease. The 
authors tested NKT function in K/BxN mice—an 
established model of rheumatoid arthritis. These 
mice spontaneously develop a progressive 
inflammatory disease that is caused by the 
deposition of autoantibodies in joints. Disease can 
be transferred to healthy recipient mice by 
injecting them with K/BxN serum.
Kim et al. now show that mice lacking NKT 
cells develop only mild joint inflammation when 
given K/BxN serum. This protection was 
reversed if the deficient mice were 
reconstituted with NKT cells.
The nonarthritic mice lacking NKT cells 
had high levels of TGF-
 
 
 
1 in their joints, which 
dropped as soon as the NKT cells arrived on the 
scene. Blocking TGF-
 
 
 
1 in the same NKT cell–
deficient mice increased joint swelling, 
suggesting a protective role for this cytokine. 
Suppression of TGF-
 
 
 
1 production depended 
on the ability of the NKT cells to produce both 
IL-4 and IFN-
 
 
 
.
Many questions remain unanswered. Future 
studies might reveal which cells produce the 
TGF-
 
 
 
1 in the joints, how TGF-
 
 
 
1 prevents 
arthritis, what attracts NKT cells to the joint, 
and how NKT cells suppress TGF-
 
 
 
1 
production.
NKT cells aggravate arthritis by blocking TGF- .
 
MBL is good for the heart
 
High levels of circulating mannose-binding lectin (MBL) are associated with 
lower risk of heart attack, according to a report on page 117. The 
correlation is particularly strong among diabetics and people with elevated 
cholesterol and may be a useful indicator of future risk.
MBL is a serum protein that binds to sugar residues on a broad range 
of microorganisms and promotes their clearance. MBL levels have been 
correlated with incidence of both infectious diseases and heart disease in 
some studies, but others found no such link.
The current study goes a long way toward settling the heart disease 
controversy. “This is the first study that examines levels of MBL protein in 
the context of other known risk factors for myocardial infarction,” senior 
author Helgi Valdimarsson points out. This stratified analysis revealed a 
particularly strong link between MBL levels and the already increased risk 
of heart attack in diabetics and people with elevated cholesterol.
Measuring MBL protein levels may also be more reliable than earlier 
analyses of MBL genotypes. The authors find that levels of MBL protein in 
the blood remain virtually unchanged in an individual for decades, whereas 
protein levels among people with the same genotype may vary widely.
Based on unpublished in vitro binding data, the authors suggest that 
MBL may protect against myocardial infarction in vivo by binding to and 
helping clear the oxidized forms of cholesterol that build up in arteries. 
This type of cholesterol is abundant in diabetic patients, which may explain 
why high levels of MBL are particularly good news for these 
individuals.  
 
Surviving low oxygen
 
Hypoxia-inducible factor–1
 
 
 
 (HIF-1
 
 
 
) prolongs the life of oxygen-
deprived neutrophils by inducing NF-
 
 
 
B–driven survival signals, according
to a study by Walmsley et al. on page 105. HIF-1
 
 
 
, a transcription factor
induced by low oxygen, is required for myeloid cell function but has
never been linked to myeloid apoptosis. Walmsley et al. now show
that cells lacking this protein are robbed of the ability to resist apoptosis
in low-oxygen environments like those encountered in wounds and
inflamed tissues.
Neutrophils must function in adverse
environments where oxygen and nutrient
supplies are low. To do this, they turn on
HIF-1
 
 
 
, which drives the synthesis of en-
zymes that make ATP anaerobically. In mice
whose myeloid cells lack HIF-1
 
 
 
, the cells
quickly lose their ATP supplies and thus have
no energy to migrate or function in response
to inflammatory stimuli.
Neutrophils also delay apoptosis during
hypoxia, and the authors now show HIF-1
 
 
 
is required for this delay. The accelerated
death could be mimicked in HIF-1
 
 
 
–positive
cells by blocking NF-
 
 
 
B, suggesting a key
role for this transcription factor in pro-
longing survival. The authors speculate that the ability of HIF-1
 
 
 
 to
induce neutrophil survival might contribute to a delayed resolution of in-
flammation, making a bad situation even worse.
Neutrophils no longer survive 
hypoxia in the absence of 
HIF-1 .
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